「fo」の検索結果
126件：56～60件目を表示
-
General Announcement: Nov 26, 2024 Senju Pharmaceutical Co., Ltd. Launch and Distribution of “MIEr for ImageFS” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution ...
https://www.senju.co.jp/system/files/content_news/2024-11/ENG_20241126.pdf -
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
Dry Eye Disease 1/2 SJP-0132 United States Completed NCT04139122 Disclaimer This website provides information on clinical trials sponsored by SENJU PHARMACEUTICAL Co., Ltd. (hereinafter referred to as...
https://www.senju.co.jp/english/rd/trial.html -
Business Activities | About Senju | SENJU Pharmaceutical
ering path in ophthalmic pharmaceuticals. In the hope of developing even more original new products for the future, we have begun to take on the challenge of the five senses. Human innate instincts an...
https://www.senju.co.jp/english/about/business/ -
al Announcement: September 3, 2024 Senju Pharmaceutical Co., Ltd. Acquisition of Marketing Approval for “ Mytear LUMIFY” Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuh...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903.pdf -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
non-clinical ocular instillation toxicity studies of SJP-0132, a TRPV1 antagonist, a novel eye drop for dry eye disease Hideya Yonekura, Kotaro Yamada, Gen Suzuki, Yu Haranosono, Yoshinori Yamagiwa, I...
https://www.senju.co.jp/english/rd/society/